Insights

Research Leadership The Duke Human Vaccine Institute's prominent position in global infectious disease research and vaccine development indicates a strong potential demand for advanced research tools, partnerships, and funding collaboration opportunities to enhance their scientific capabilities.

Technological Innovation Duke’s work on developing cutting-edge platforms such as high-resolution microscopes and rail safety technologies presents opportunities for suppliers of advanced laboratory equipment, imaging systems, and scientific software solutions.

Funding and Growth With significant funding of approximately 1.7 billion dollars and revenues reaching up to 100 million dollars, Duke has the financial capacity to invest in innovative research infrastructure and strategic collaborations with technology providers or service vendors.

Educational and Innovation Initiatives Duke’s active engagement in leadership forums and innovation centers suggests opportunities to partner in educational programs, training initiatives, and collaborative research grants aimed at scientific excellence and workforce development.

Operational and Compliance Challenges Recent investigations into legal and compliance issues highlight a need for compliance management solutions and legal consulting services to support Duke in maintaining regulatory standards and ethical research practices.

The Duke Human Vaccine Institute Tech Stack

The Duke Human Vaccine Institute uses 8 technology products and services including Microsoft Advertising, Renderforest, DreamWeaver, and more. Explore The Duke Human Vaccine Institute's tech stack below.

Microsoft Advertising

Advertising

Renderforest

Editors

DreamWeaver

Editors

OnBase

Enterprise Content Management

Netid

Governance, Risk And Compliance

reCAPTCHA

Security

LabVIEW

Visualisation Software

AddToAny

Widgets

The Duke Human Vaccine Institute Email Formats	Example	Percentage
First.Last@duke.edu	John.Doe@duke.edu	82%
FLast@duke.edu	JDoe@duke.edu	12%
FirstLast@duke.edu	JohnDoe@duke.edu	5%
FL@duke.edu	JD@duke.edu	1%

The Duke Human Vaccine Institute Email Formats

Example

Percentage

First.Last@duke.edu

John.Doe@duke.edu

82%

FLast@duke.edu

JDoe@duke.edu

12%

FirstLast@duke.edu

JohnDoe@duke.edu

FL@duke.edu

JD@duke.edu

Frequently Asked Questions

What is The Duke Human Vaccine Institute's official website and social media links?

The Duke Human Vaccine Institute's official website is duke.edu and has social profiles on LinkedIn.

What is The Duke Human Vaccine Institute's NAICS code?

The Duke Human Vaccine Institute's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does The Duke Human Vaccine Institute have currently?

As of December 2025, The Duke Human Vaccine Institute has approximately 201 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Of Staff: K. C.Chief Clinical Director: M. R.Chief Of Staff: K. C.. Explore The Duke Human Vaccine Institute's employee directory with LeadIQ.

What industry does The Duke Human Vaccine Institute belong to?

The Duke Human Vaccine Institute operates in the Research Services industry.

What technology does The Duke Human Vaccine Institute use?

The Duke Human Vaccine Institute's tech stack includes Microsoft AdvertisingRenderforestDreamWeaverOnBaseNetidreCAPTCHALabVIEWAddToAny.

What is The Duke Human Vaccine Institute's email format?

The Duke Human Vaccine Institute's email format typically follows the pattern of First.Last@duke.edu. Find more The Duke Human Vaccine Institute email formats with LeadIQ.

How much funding has The Duke Human Vaccine Institute raised to date?

As of December 2025, The Duke Human Vaccine Institute has raised $1.7B in funding. The last funding round occurred on Dec 23, 2021 for $7.5M.

When was The Duke Human Vaccine Institute founded?

The Duke Human Vaccine Institute was founded in 1990.

The Duke Human Vaccine Institute

Q: What technology does The Duke Human Vaccine Institute use?

The Duke Human Vaccine Institute's tech stack includes CourseLeaf, Red Hat, Red Hat Enterprise Linux Server, Elementor, Oracle PeopleSoft.

Research ServicesNorth Carolina, United States201-500 Employees

The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases. DHVI plays an integral leadership role in the Global HIV/AIDS Vaccine Enterprise and is a pioneer in emerging infections and biodefense research. By focusing on the scientific “bottlenecks” for the development of HIV, influenza, SARS-CoV-2, and other vaccines and therapeutics, DHVI investigators continue to make significant contributions to overcome global health challenges on behalf of society.

Our Mission:
To develop vaccines and therapeutics against diseases of global importance while training the next generation of scientists.

Our Values: The DHVI supports the development of vaccines and therapeutics through a commitment to Innovation, Collaboration, and Excellence.

Excellence through a commitment to respect, integrity, and safety
Collaboration through embracing change and cultivating diversity to achieve synergy
Innovation through ingenuity and the pursuit of continuous improvement

Insights

Similar companies to The Duke Human Vaccine Institute

National Institute of Allergy and Infectious Diseases (NIAID)

PATH

Bill & Melinda Gates Foundation

International Vaccine Institute (IVI)

Mymetics Corporation